Clinical Trial

GGO-dominant PPLs Diagnosis Using CLE and ssRAB-guided Cryobiopsy

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 6, 2025 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of the study is to evaluate the diagnostic performance and safety of cryobiopsy for ground-glass opacity (GGO)-dominant peripheral pulmonary lesions (PPLs) under the guidance of shape-sensing robotic-assisted bronchoscopy (ssRAB) combined with confocal laser endomicroscopy (CLE). Additionally, the study aims to establish CLE interpretation criteria for GGO-dominant PPLs based on histopathological characteristics and validate the proposed criteria.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-02.
Trial Details
NCT Number NCT06910046
Lead Sponsor Shanghai Chest Hospital
Conditions Lung Ground-Glass Opacity
Enrollment 119 participants
Start Date 2025-04
Primary Completion 2026-04 (estimated)
Study Completion 2027-04 (estimated)
Updated on ClinicalTrials.gov 2025-04-06